Drug immunoallergic reactions: Epidemiological and clinical data;Les reactions immuno-allergiques d'origine medicamenteuse: Donnees epidemiologiques et cliniques

Therapie

Volumn 55, Issue 1, 2000, Pages 13-19

  Demoly, P ^a   Messaad, D ^a   Benahmed, S ^a   Hillaire Buys, D ^a   Blayac, J P ^a   Godard, Ph ^a   Michel, F B ^a   Bousquet, J ^a  

^a INSERM   (France)

Author keywords

Allergies; Drugs; Epidemiology

Indexed keywords

ANESTHETIC AGENT; BETA LACTAM ANTIBIOTIC; LOCAL ANESTHETIC AGENT; MACROLIDE; PARACETAMOL; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFANILAMIDE; VACCINE; DRUG;

ADVERSE DRUG REACTION; ANAPHYLACTIC SHOCK; ANTIBODY RESPONSE; BULLOUS SKIN DISEASE; CLINICAL FEATURE; CONFERENCE PAPER; DRUG HYPERSENSITIVITY; HEALTH CARE COST; HOSPITALIZATION; HUMAN; IMMUNE RESPONSE; INCIDENCE; LYMPHOCYTE PROLIFERATION; MORTALITY; PRIORITY JOURNAL; T LYMPHOCYTE; URTICARIA; ANIMAL; IMMUNOLOGY; REVIEW;

ANIMALS; DRUG HYPERSENSITIVITY; HUMANS; PHARMACEUTICAL PREPARATIONS;

EID: 0034072708     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (30)

1. Gell PGH, Coombs RRA., Lachmann PJ. Clinical Aspects of Immunology. Third edn. Oxford: Blackwell, 1975.
2. Patterson R, DeSwarte RD, Greenberger PA et al. Drug Allergy and Protocols for Management of Drug Allergies. Second edn. Providence, RI: OceanSide Publications, 1995.
3. Leynadier F. Allergies médicamenteuses. Rev Prat 1996; 46: 955-960.
4. Demoly P, Hillaire-Buys D, Blayac JP et al. Prise en charge et actualités des allergies médicamenteuses. Presse Med 1998; 27: 1406-1411.
5. Nyfeler B, Pichler WJ. The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity. Clin Exp Allergy 1997; 27: 175-181.
6. Webster AW, Thompson RA. The ampicillin rash. Clin Exp Immunol 1974; 18: 553-564.
7. Haddi E, Charpin D, Tafforeau M et al. Atopy and systemic reactions to drugs. Allergy 1990; 45: 236-239.
8. Pastorello EA, Zara C, Riario-Sforza GG et al. Atopy and intolerance of antimicrobial drugs increase the risk of reactions to acetaminophen and nimesulide in patients allergic to nonsteroidal anti-inflammatory drugs. Allergy 1998; 53: 880-884.
9. Romano A, De Santis A, Romito A et al. Delayed hypersensitivity to aminopenicillins is related to major histocompatibility complex genes. Ann Allergy Asthma Immunol 1998; 80: 433-437.
10. Kowalski ML, Woszczek G, Bienkiewicz B, Mis M. Association of pyrazolone drug hypersensitivity with HLA-DQ and DR antigens. Clin Exp Allergy 1998; 28: 1353-1358.
11. Vittorio CC, Muglia JJ. Anticonvulsiviant hypersensitivity syndrome. Arch Intern Med 1995; 155: 2285-2290.
12. Asero R. Detection of patients with multiple drug allergy syndrome by elective tolerance tests. Ann Allergy Asthma Immunol 1998; 80: 185-188.
13. Khoury L, Warrington R. The multiple drug allergy syndrome: a matched-control retrospective study in patients allergic to penicillin. J Allergy Clin Immunol 1996; 98: 462-464.
14. Coopman SA, Johnson RA, Platt R, Stern RS. Cutaneous disease and drug reactions in HIV infection. N Engl J Med 1993; 328: 1670-1674.
15. Imb JL, Pouyanne P, Haramburu F et al. Iatrogénie médicamenteuse: estimation de sa prévalence dans les hôpitaux publics français. Therapie 1999; 54: 21-27.
16. Bates DW, Cullen DJ, Laird N et al. Incidence of adverse drug events and potential adverse drug events. JAMA 1995; 274: 29-34.
17. Classen DC, Pestotnik SL, Evans RS, Burke JP. Computarized surveillance of adverse drug events in hospital patients. JAMA 1991; 266: 2847-2851.
18. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients. A meta-analysis of prospective studies. JAMA 1998; 279: 1200-1205.
19. Hunziker Th, Künzi U-P, Braunschweig S et al. Comprehensive hospital drug monitoring (CHDM): adverse skin reactions, a 20-year survey. Allergy 1997; 52: 388-393.
20. Bigby M, Jick S, Jock H, Arndt K. Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982. JAMA 1986; 256: 3358-3363.
21. Lenler-Petersen P, Hansen D, Andersen M et al. Drug-related fatal anaphylactic shock in Denmark 1968-1990. A study based on notifications to the Committee on Adverse Drug Reactions. J Clin Epidemiol 1995; 48: 1185-1188.
22. Bochner BS, Lichtenstein LM. Anaphylaxis. N Engl J Med 1991; 324: 1785-1790.
23. Demoly P, Kropf R, Bircher A, Pichler WJ. Drug hypersensitivity: questionnaire. Allergy 1999; 54: 999-1003.
24. Begaud B, Evreux JC, Jouglard J, Lagier G. Imputabilité des effets inattendus ou toxiques des médicaments. Actualisation de la méthode utilisée en France. Therapie 1985; 40: 111-114.
25. Adkinson NF Jr, Thompson WL, Maddrey WC et al. Routine use of penicillin skin testing as an inpatient service. N Engl J Med 1971; 285: 22-29.
26. Barbaud A, Reichert-Penetrat S, Tréchot P et al. The use of skin testing in the investigation of cutaneous adverse drug reactions. Br J Dermatol 1998; 139: 49-58.
27. Kraft D, Hedin H, Richter N et al. Immunoglobulin class and subclass distribution of dextran reactive antibodies in human reactors and non reactors to clinical dextran. Allergy 1982; 37: 481-489.
28. Guilloux L, Ricard-Blum S, Ville G, Motin J. Histamine release assay and radioimmunoassay for the detection of IgE antibodies against neuromuscular blocking drugs. Ann Fr Anesth Reanim 1993: 12: 182-186.
29. Demoly P, Lebel B, Messaad D et al. Predictive capacity of histamine release for the diagnosis of drug allergy. Allergy 1999; 54: 500-506.
30. De Week AL, Stadler BM, Urwyler A et al. Cellular allergen stimulation test (CAST). A new dimension in allergy diagnostics. ACI News 1993; 5: 9-14.